CHU Angers

Running trials

• Not yet recruiting

  Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A

  NCT07830693· Source

• Not yet recruiting

  Real World Positioning of Tyrosine Kinase Inhibitors (TKIs) Within Systemic Treatment Strategies for Advanced Neuroendocrine Tumors (NETs)

  NCT07890012· Source

• Not yet recruiting

  Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas

  NCT07924384· Source

• Not yet recruiting

  Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty

  NCT07644377· Phase 3· Source

• Not yet recruiting

  Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France

  NCT07851844· Source

• Recruiting

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· Phase 3· Source

• Not yet recruiting

  Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

  NCT07547033· Source

• Not yet recruiting

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Source

• Not yet recruiting

  Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

  NCT07463768· Phase 2· Source

• Recruiting

  Evaluation of Skin Tests in Biotherapy Allergies

  NCT06971848· Source

• Recruiting

  Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

  NCT07378072· Source

• Not yet recruiting

  Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

  NCT07497750· Source

• Recruiting

  Cohort of Patients With Chronic Myelomonocytic Leukemia

  NCT07512882· Source

• Not yet recruiting

  Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease

  NCT07409597· Source

• Recruiting

  Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)

  NCT07317102· Source

• Recruiting

  LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.

  NCT07202897· Phase 3· Source

• Recruiting

  Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

  NCT05126914· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· Phase 3· Source

• Recruiting

  Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention

  NCT06599879· Source

• Recruiting

  Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

  NCT06618703· Source

• Recruiting

  Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke

  NCT07065929· Source

• Active, not recruiting

  French Prospective Multicentric Study in Real World

  NCT07039942· Source

• Recruiting

  Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)

  NCT07243132· Source

• Not yet recruiting

  Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

  NCT06263816· Phase 3· Source

• Not yet recruiting

  Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

  NCT06931704· Phase 2· Source

• Recruiting

  Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse

  NCT06649253· Source

• Recruiting

  Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.

  NCT07117058· Source

• Not yet recruiting

  Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer

  NCT06869005· Source

• Recruiting

  Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

  NCT06487273· Source

• Active, not recruiting

  Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

  NCT06634160· Source

• Recruiting

  Epidemiological Data on Mast Cell Pathologies in France

  NCT06186856· Source

• Not yet recruiting

  Clinical Evaluation of A neW Management Strategy for Patients With pArKinson's disEase usiNg an Innovative telemonitorING (AWAKENING)

  NCT06401395· Source

• Recruiting

  Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

  NCT06427304· Source

• Recruiting

  FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

  NCT06393816· Phase 2· Source

• Recruiting

  CARE1 Pragmatic Clinical Trial

  NCT06364631· Phase 3· Source

• Recruiting

  Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.

  NCT06119516· Source

• Recruiting

  A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

  NCT06541652· Source

• Recruiting

  Treatment Resistant Depression and Vagus Nerve Stimulation

  NCT05952674· Source

• Recruiting

  EWALL-PH OBSERVARTORY 2022

  NCT07684131· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Source

• Recruiting

  Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

  NCT06083129· Phase 3· Source

• Recruiting

  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  NCT05192980· Source

• Recruiting

  Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

  NCT05917405· Phase 2· Source

• Recruiting

  Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

  NCT05625724· Phase 3· Source

• Active, not recruiting

  ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

  NCT05928416· Source

• Recruiting

  Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

  NCT05772559· Source

• Recruiting

  Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

  NCT05440838· Source

• Active, not recruiting

  Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

  NCT05825573· Phase 3· Source

• Recruiting

  Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock

  NCT05788120· Source

• Recruiting

  Clonal Architecture of ASXL1-mutated Myelofibrosis

  NCT05710211· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers13 recruiting
• Acute myeloid leukemia5 recruiting
• Lung cancer5 recruiting
• Myeloproliferative neoplasms4 recruiting
• Liver and biliary tract cancer3 recruiting
• Neuroendocrine tumours3 recruiting
• Obesity3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Amyloidosis2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
• Colorectal cancer2 recruiting
• Epilepsy2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Follicular lymphoma2 recruiting
• High blood pressure2 recruiting
• Kidney cancer2 recruiting
• Multiple myeloma2 recruiting
• Sarcoma2 recruiting
• Stroke2 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Chronic kidney disease1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Cystic fibrosis1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Gastric and esophageal cancer1 recruiting
• Haemophilia1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Huntington's disease1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Mantle cell lymphoma1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroblastoma1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy

  NCT06054347· Source

• Completed

  Intubation of Obese Patients in the Operating Room With or Without Face Mask Ventilation

  NCT05930678· Source

• Terminated

  CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

  NCT05546606· Source

• Completed

  A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

  NCT05218655· Phase 3· Source

• Completed

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Source

• Completed

  Multicenter Validation of the Salivary miRNA Signature of Endometriosis

  NCT05244668· Source

• Completed

  Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

  NCT04890028· Source

• Completed

  Evaluation of an Environmental Counsellor's Home Stay in Children Treated for Asthma or Allergic Rhinitis Via a Standardized Medical Questionnaire Randomized Controlled Superiority Trial in Parallel Arms, Multicentric (EvalPCE)

  NCT04927689· Source

• Completed

  Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients

  NCT04802954· Source

• Terminated

  Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure

  NCT04554277· Source

• Completed

  Social Cognition in Patients With Amyotrophic Lateral Sclerosis

  NCT04406675· Source

• Completed

  Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

  NCT04316520· Source

• Completed

  Home Airway Clearance in CF Patients

  NCT04096664· Source

• Completed

  Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

  NCT03948724· Source

• Completed

  Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients

  NCT03690115· Phase 2· Source

• Completed

  Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )

  NCT04108728· Source

• Completed

  Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

  NCT03869476· Source

• Completed

  Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma

  NCT04267146· Phase 1/2· Source

• Terminated

  "Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"

  NCT03876561· Source

• Completed

  Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

  NCT04069468· Source

• Completed

  Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

  NCT03249870· Phase 2· Source

• Completed

  Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

  NCT03268954· Phase 3· Source

• Completed

  Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

  NCT02784171· Phase 2/3· Source

• Completed

  Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

  NCT01868269· Phase 3· Source